Result of AGM

Accrol Group Holdings PLC
24 October 2023
 

24 October 2023

 

Accrol Group Holdings plc

("Accrol", the "Company" or the "Group")

AIM: ACRL

 

Result of 2023 Annual General Meeting

 

Accrol (AIM: ACRL), the UK's leading independent tissue converter, announces that all of the resolutions set out in the Notice of AGM were passed by the requisite majority at the Company's AGM, held earlier today.

 

Details of the proxy votes received by the Company are as follows:

 

Resolution

For

Against

Withheld

 

No. of votes

%

No. of votes

%

No. of votes

1. To receive the Annual Report and Accounts

219,819,362

99.97

65,673

0.03

0

2. To appoint BDO as Auditor and authorise the directors to fix their remuneration

219,781,647

99.96

90,747

0.04

12,641

3. To approve the Directors' Remuneration Report

212,665,237

96.72

7,207,157

3.28

12,641

4. To re-elect Chris Welsh as a Director

219,334,006

99.75

548,180

0.25

2,849

5. To authorise the Directors to allot relevant securities

219,313,827

99.74

561,635

0.26

9,573

6. To authorise the Directors to allot equity securities for cash without making a pre-emptive offer to shareholders*

214,032,998

97.34

5,842,464

2.66

9,573

7. To authorise the Directors to make market purchases of ordinary shares*

214,174,005

97.4

5,710,716

2.6

314

 

 

*Special resolution

 

Notes:

 

1.

Proxy appointments which gave discretion to the Chairman of the AGM have been included in

"For" total for the appropriate resolution.

2.

Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.

3.

A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against".

4.

The number of shares in issue on 17 October 2023 was 318,878,097 with no shares in treasury.

5.

The full text of the resolutions passed at the AGM is available in the Notice of AGM on the Company's website:

https://www.accrol.co.uk/investors/company-reports-presentations-and-circulars/

 

 

For further information, please contact:

 

 


Accrol Group Holdings plc


Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer


Chris Welsh, Chief Financial Officer


 


Zeus (Nominated Adviser & Broker) 

 

Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King

Tel: +44 (0) 203 829 5000



Shore Capital Stockbrokers (Joint Broker)

Tel: +44 (0) 20 7408 4090

Malachy McEntyre/ Mark Percy / James Thomas /


Isobel Jones

 


Belvedere Communications Limited


Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525


accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from five manufacturing sites which together supply c.21.5% (volume) of the UK tissue market valued at c£2.5bn at retail sales value.

 

For more information, please visit www.accrol.co.uk.

 

Link for Accrol Today video: https://www.accrol.co.uk/our-business/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100